Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Florida Medicaid Has Negotiated $66 Mil. In Supplemental Rebates

Executive Summary

Florida Medicaid's supplemental rebate negotiations have produced agreements that guarantee savings of $66 mil. thus far, the state said in its response to PhRMA's lawsuit against the program.

You may also be interested in...



Prevacid Share Gains Show Impact Of Prior Authorization – Florida Report

TAP's Prevacid is one of the big market-share winners under Florida's Medicaid supplemental rebate program, according to an analysis prepared for the state legislature

Prevacid Share Gains Show Impact Of Prior Authorization – Florida Report

TAP's Prevacid is one of the big market-share winners under Florida's Medicaid supplemental rebate program, according to an analysis prepared for the state legislature

Bristol Follows Pfizer Formula For Access To Florida Medicaid

Bristol-Myers Squibb's agreement with Florida Medicaid will call for the company to spend at least $4.4 mil. on disease management programs in exchange for formulary status for all of its products.

UsernamePublicRestriction

Register

PS038471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel